Clinical Trial Update: MTD Study PXD-101 in Combination With Paclitaxel + Carboplatin in Chemotherapy-Naive Patients With Stage IV NSCLC [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for MTD study of PXD-101 in combination with paclitaxel and carboplatin in chemotherapy-naive patients with Stage IV non-small cell lung c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• PACLITAXEL (PACLITAXEL)
• PXD-101

Snippet

Sponsor: Acrotech Biopharma Inc. | Conditions: Stage IV Non-small Cell Lung Cancer | Phase 1, Phase 2 | Status: COMPLETED